Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients

Ítems similars

• Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs
  per: Yoshimura, Reiji, et al.
  Publicat: (2014)
• Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia
  per: Yoshimura, Reiji, et al.
  Publicat: (2016)
• No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients
  per: Yoshimura, Reiji, et al.
  Publicat: (2012)
• Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder
  per: Atake, Kiyokazu, et al.
  Publicat: (2014)
• Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorder
  per: Yoshimura, Reiji, et al.
  Publicat: (2014)